医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NanoSpeed Announces Distribution Partnership with Unilab for Test4D™

2015年02月10日 AM01:33
このエントリーをはてなブックマークに追加


 

EDMONTON, Alberta

NanoSpeed is pleased to announce that they have appointed an exclusive distributor in the Philippines for their 25-OH Vitamin D deficiency test kit – Test4D™. Unilab Laboratories, Inc. (“Unilab”) is an independent manufacturer and distributor of healthcare products based in the Philippines.

“We are very pleased to begin growing our distributor network Asia, starting in the Philippines and with Unilab,” said Dr. Seema Gupta, President of NanoSpeed Diagnostics, Inc., a leading diagnostics company focused on providing portable, innovative and rapid testing solutions. “Unilab has proven to themselves to be a strong presence as the largest pharmaceutical centre in the Philippines. We are very pleased to welcome them to our global distribution network.”

Test4D™ is a patented and unique point-of-care test that provides information on Vitamin D deficiency within 10 minutes. This test requires only a single drop of blood from the patient and costs 90% less when compared to other standard or conventional tests.

Test4D® is not approved for commercial use in Canada or the United States and is limited by federal law to research or investigational use only.

About Unilab Laboratories, Inc.
Unilab is the biggest pharmaceutical company in the Philippines, with a market share of some 20 percent which it has consistently maintained for more than three decades. Its portfolio includes some of the biggest prescription and consumer healthcare brands in the country.

For more information, please visit www.unilab.com.ph.

About NanoSpeed Diagnostics Inc.
NanoSpeed, incorporated in 2009, develops proprietary diagnostic/screening test kit platforms based on their Lateral Flow Immuno Assay and Lab-on-a-Chip technologies. These technological advancements provide patients with cost effective and reliable testing tools that will address the increasing needs of the healthcare industry, regulatory agencies and consumers.

About Vitamin D deficiency and Test4D™:
Vitamin D deficiency is a common problem in Canada, where 60% of adults have suboptimal levels of 25-OH vitamin D. Vitamin D deficiency has been associated with abnormalities in absorption of calcium, phosphorus, and bone metabolism; cardiovascular disease; diabetes; cancer; osteomalacia and osteoporosis in adults; and rickets in children. Deficient vitamin D levels are typically the result of an inadequate intake of vitamin D through sunlight, diet, or supplements, or due to malabsorptive disorders.

25-OH vitamin D levels are currently measured through laboratory testing. Over the past decade, there has been an incremental surge in the demand for vitamin D testing, resulting in increasing costs to government supported healthcare systems. An alternative to laboratory testing is Point-of-Care-Testing (POCT), medical testing that occurs outside of a clinical laboratory and near the patient. Potential advantages of POCT include reduction in errors and costs to the healthcare system, and the provision of quick clinical diagnoses.

To address the demands of vitamin D testing, NanoSpeed Diagnostics Inc. developed Test4D™, a POCT device for the qualitative detection of 25-OH Vitamin D in human blood obtained via fingertip puncture.

Test4D™ is available for commercial sale through certain distributors, or can be purchased for research purposes directly from NanoSpeed.

CONTACT

NanoSpeed Diagnostics Inc.
Seema Gupta, 780-701–0022 x222
President

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent